; and (ii) shall expire not later than 2 years after the date on which the temporary order becomes effective, except that the Attorney General may, during the pendency of proceedings under paragraph (2), extend the temporary order for not more than 6 months. (C) Notice to Secretary of Health and Human Services (i) In general The Attorney General shall transmit notice of a temporary order proposed to be issued under subparagraph (A) to the Secretary of Health and Human Services. (ii) Consideration In issuing a temporary order under subparagraph (A), the Attorney General shall take into consideration any comments submitted by the Secretary of Health and Human Services in response to a notice transmitted under this subparagraph. (D) Effect of permanent scheduling A temporary order issued under subparagraph (A) shall be vacated upon the issuance of a permanent order issued under paragraph (2). (E) Judicial review A temporary order issued under subparagraph (A) shall not be subject to judicial review. (2) Permanent orders (A) In general The Attorney General may by rule issue a permanent order adding a drug or other substance to the definition of the term SARM under section 102(57) if the drug or other substance satisfies the criteria for being considered a SARM under that section. (B) Timing The Attorney General may commence a rulemaking under subparagraph (A) simultaneously with the issuance of a temporary order under paragraph (1). . (d) Labeling requirements (1) In general Section 305 of the Controlled Substances Act (21 U.S.C. 825) is amended by adding at the end the following: (f) False labeling of SARMs (1) Prohibition It shall be unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a SARM or product containing a SARM, unless the SARM or product containing the SARM bears a label clearly identifying the SARM or product containing the SARM by the nomenclature used by the International Union of Pure and Applied Chemistry. (2) Exemption (A) In